ICELogo_1000x188 (2).jpg

ICE Partner Banner.JPG

Partnership Opportunities

The Increasing Clinical Effectiveness Initiative (ICE) exists to demonstrate the laboratory’s value in providing a measurable positive impact on patient outcomes. 

If you have questions or would like more information, please contact us at rbaker@clma.org

Why ICE?

The Increasing Clinical Effectiveness Initiative (ICE) exists to demonstrate the laboratory’s value in providing a measurable positive impact on patient outcomes. Today, the Initiative is executed as an abstract submission process and awards program that showcases studies of improved patient outcomes championed by laboratory physicians and scientists. Participation in ICE requires the submission of abstracts that describe testing-related interventions and the quantifiable positive impact for patients they produced. ICE winner recognition is held at the Clinical Laboratory Management Association’s (CLMA) annual KnowledgeLab conference and other venues such as IFCC EuroMedLab 2017 in Athens, Greece. In its first year, four of the highest rated abstracts were selected for oral presentation at CLMA’s KnowledgeLab 2015. Other submissions, that met the minimum criteria, were invited to prepare posters for KnowledgeLab.

How to Get Involved 

Become either an Industry or Organizational Partner to support the Initiative and receive benefits at varying degrees.

  • Industry Partner – Typically vendors, solution providers or enterprises who contribute funding to CLMA. In return, CLMA will provide recognition for the company with ICE communications and positioning along with additional benefits. Industry Partners are broken into segments based on sponsorship amount. Industry Partner packages range from $5,000 to $40,000.
  • Organizational Partner – Governmental or non-profit organizations who promote and/or endorse ICE, with the intended outcome of increasing ICE abstract submissions and general brand credibility. Funding is not typically involved.